太极TAIJI品牌怎么样 申请店铺

我要投票 太极TAIJI在乌鸡白凤丸行业中的票数:647 更新时间:2026-01-15
太极TAIJI是哪个国家的品牌?「太极TAIJI」是重庆太极实业(集团)股份有限公司旗下著名品牌。该品牌发源于重庆,由创始人白礼西在1992期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。

外推网助力太极TAIJI品牌出海!将品牌入驻外推网,定制太极TAIJI品牌推广信息,可以显著提高太极TAIJI产品曝光,简直是跨境电商爆单神器!目前仅需1000元/年哦~

太极TAIJI怎么样

太极集团有限公司(简称太极集团)是中国企业500强之一,中国医药工业10强,资产200亿元,拥有“太极集团”(重庆太极实业(集团)股份有限公司)、“桐君阁”(重庆桐君阁股份有限公司)两家上市公司。“太极”(TAIJI)为中国首批驰名保护,OTC品牌药企第一名,2014年集团销售总额达230亿元,2021年将跨越千亿大关。

太极集团拥有10000家药房、13000名员工、20多家医药商业公司、13家制药厂及太极医药研究院、重庆中药研究院两大研发机构。1998年,太极集团与国内外15所院校合作建立博士后工作站;1999年,太极集团技术中心被认定为国家级企业技术中心;2013年,获国家批准建立太极院士专家工作站,中国工程院近20位院士成为太极研发顾问。

太极集团现有中西药品种1500多个、全国独家生产品种50多个、获得国家中药保护品种50多个、国家基药品种165个,获国家专利120项、年销售额逾亿元的品种15个。

太极集团的快速发展主要得益于日益增强的科研开发能力,日益完善的国内市场网络,日益成熟的信息化管理,先进的生产装备,畅销的外贸营销渠道,一流的员工队伍和管理团队,颇具中国特色的管理经验。更为重要的是,太极员工多年受“忠诚、责任、团结、努力”的太极精神熏陶,充满了“光大太极、振兴中华”的必胜信念。

习近平、张德江、江泽民、李鹏、温家宝、吴邦国、曾庆红、邹家华等党和国家领导人多次亲临太极集团视察工作,充分肯定太极集团的发展壮大之路,江泽民同志亲笔书写“太极集团”四个金光闪闪的大字予以鼓励。

阴阳互根方能相长,阴阳平衡万事万物方能和谐发展。太极集团渴望交流,期待合作,愿和您为中国医药事业走向世界而共同努力!

太极急支糖浆

批准文号:国药准字Z33020852

药品规格:每瓶装100毫升、200毫升

功能与主治:清热化痰、宣肺止咳。用于外感风热所致的咳嗽,症见发热、恶寒、胸膈满闷、咳嗽咽痛;急性支气管炎、慢性支气管炎急性发作见上述症候者。

用法与用量:口服。一次20~30ml,一日3~4次;儿童一岁以内一次5ml,一岁至三岁一次7ml,三岁至七岁一次10ml,七岁以上一次15ml,一日3~4次。

生产厂家:太极集团浙江东方制药有限公司

太极天胶

批准文号:国药准字Z62021196

药品规格:250克/盒

功能与主治:补血滋阴,润燥,止血。用于血虚萎黄,眩晕心悸,心烦不眠,肺燥咳嗽。

用法与用量:烊化兑服,3—9克

生产厂家:太极集团甘肃天水羲皇阿胶有限公司

Taiji Group Co., Ltd. (hereinafter referred to as Taiji Group) is one of the top 500 Chinese enterprises, one of the top 10 Chinese pharmaceutical industries, with assets of 20 billion yuan. It has two listed companies, Taiji Group (Chongqing Taiji industry (Group) Co., Ltd.) and TongJunGe (Chongqing TongJunGe Co., Ltd.). Taiji is one of the first batch of well-known protection companies in China, and the first OTC brand pharmaceutical enterprise. In 2014, the group's total sales reached 23 billion yuan, and in 2021, it will surpass 100 billion. Taiji Group has 10000 pharmacies, 13000 employees, more than 20 pharmaceutical commercial companies, 13 pharmaceutical factories, Taiji Pharmaceutical Research Institute and Chongqing Traditional Chinese Medicine Research Institute. In 1998, Taiji Group cooperated with 15 universities at home and abroad to establish a postdoctoral workstation; in 1999, Taiji Group Technology Center was recognized as a national enterprise technology center; in 2013, Taiji Group Technology Center was approved by the state to establish a Taiji academician expert workstation, and nearly 20 academicians of Chinese Academy of Engineering became Taiji R & D consultants. Taiji Group has more than 1500 varieties of Chinese and Western medicine, more than 50 national exclusive production varieties, more than 50 national protected varieties of traditional Chinese medicine, 165 national basic medicine varieties, 120 national patents, and 15 varieties with annual sales of more than 100 million yuan. The rapid development of Taiji Group is mainly due to the increasing research and development ability, the increasingly perfect domestic market network, the increasingly mature information management, advanced production equipment, the best-selling foreign trade marketing channels, the first-class staff and management team, and quite unique management experience in China. What's more, Taiji employees have been influenced by Taiji spirit of "loyalty, responsibility, unity and hard work" for many years, and are full of the belief of "Everbright Taiji and rejuvenation of China". Xi Jinping, Zhang Dejiang, Jiang Zemin, Li Peng, Wen Jiabao, Wu Bangguo, Zeng Qinghong, Zeng Qinghong and other party and state leaders visited Tai Chi Group for many times to inspect the work of Taiji group and fully affirmed the development and expansion of Taiji group. Comrade Hu personally wrote the four golden glittering characters of Taiji group to encourage them. Only when Yin and yang are mutually rooted can they grow, and when Yin and yang balance everything, can everything develop harmoniously. Taiji Group is eager to communicate and cooperate with you. We are willing to work with you for the development of Chinese medicine in the world! Approval No. of taijijijizhi syrup: gyzz z33020852 drug specification: 100ml and 200ml per bottle function and indications: clearing heat and resolving phlegm, promoting lung and relieving cough. It is used for cough caused by exogenous wind heat. Symptoms include fever, cold, chest and diaphragm fullness, cough and sore throat; acute bronchitis and chronic bronchitis with acute attack. Usage and dosage: oral. 20-30ml for one time, 3-4 times a day; 5ml for children under one year old, 7ml for children from one to three years old, 10ml for children from three to seven years old, 15ml for children over seven years old, 3-4 times a day. Manufacturer: Taiji Tianjiao of Zhejiang Oriental Pharmaceutical Co., Ltd. of Taiji group approval No.: gyzz z62021196 drug specification: 250G / box function and indications: nourishing blood and Yin, moistening dryness, hemostasis. It is used for deficiency of blood, yellowing, vertigo, palpitation, restlessness, lung dryness and cough. Usage and dosage: shunyua mixed service, 3-9g manufacturer: Taiji Group Gansu Tianshui Xihuang donkey hide gelatin Co., Ltd

本文链接: https://brand.waitui.com/0814962ca.html 联系电话:请联系客服添加 联系邮箱:请联系客服添加

外推网广告位招租,每天只要9块9

7×24h 快讯

格力电器:2025年中期权益分派每10股派10元,股权登记日为1月22日

36氪获悉,格力电器公告,公司2025年中期权益分派方案为:以现有总股本剔除已回购股份后的55.85亿股为基数,向全体股东每10股派发现金股利10元(含税),不送红股,不以资本公积金转增股本,共计派发现金股利55.85亿元。股权登记日为2026年1月22日,除权除息日为2026年1月23日。

36分钟前

新华百货:不存在市场传闻注入半导体等相关资产事项

36氪获悉,新华百货发布股票交易异常波动公告,公司股票连续三个交易日内收盘价格涨幅偏离值累计超过20%。经核实,除公司已披露的事项外,不存在应披露而未披露的重大事项。公司关注到有个别投资者在相关媒体平台发表不实言论及传闻,针对公司控股股东协议转让部分股份事宜,将涉及后期向公司注入半导体、集成电路、芯片等相关资产,引发公司股票市场波动。经公司与控股股东及控股股东股权受让各方(杭州景祺电子信息合伙企业(有限合伙)及厦门联芯美企业管理合伙企业(有限合伙))沟通核实,不存在市场传闻所述事项。

36分钟前

摩根士丹利邢自强:2040年将迎来中国医药界的DeepSeek时刻

摩根士丹利中国首席经济学家邢自强指出,中国在科技创新领域正展现“星辰大海”式突破,三大核心优势:产业链集群、理工科人才红利、超大市场规模,这些难以被其他经济体复制。他还指出,中国生物制药行业迎来爆发式增长,“我们测算,到了2040年,基本上美国FDA批准的新的创新药里,三分之一以上来自于中国,这也是中国医药界的DeepSeek时刻。”(财联社)

36分钟前

美锦能源:预计2025年净亏损8.5亿元-12.5亿元

36氪获悉,美锦能源发布业绩预告,预计2025年净利润亏损8.5亿元-12.5亿元,上年同期亏损11.43亿元。报告期内,受市场环境影响,煤炭、焦炭价格全年整体呈下行态势,导致公司主要产品毛利率持续承压。

36分钟前

海南发展:预计2025年净亏损4.4亿元-5.65亿元

36氪获悉,海南发展发布业绩预告,预计2025年净利润亏损4.4亿元-5.65亿元,上年同期亏损3.79亿元。报告期内,受光伏玻璃行业影响,控股子公司海控三鑫持续亏损。公司申请其破产清算。在责任范围内承担海控三鑫超额亏损,导致公司较上年同期增亏。

36分钟前

本页详细列出关于太极TAIJI的品牌信息,含品牌所属公司介绍,太极TAIJI所处行业的品牌地位及优势。
咨询